株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

細胞培養市場の予測 〜2020年:設備 (バイオリアクター・容器)・消耗品 (FBS・ABS・培地・試薬)・用途 (治療・幹細胞)・エンドユーザー別

Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020

発行 MarketsandMarkets 商品コード 308211
出版日 ページ情報 英文 253 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
細胞培養市場の予測 〜2020年:設備 (バイオリアクター・容器)・消耗品 (FBS・ABS・培地・試薬)・用途 (治療・幹細胞)・エンドユーザー別 Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020
出版日: 2016年02月22日 ページ情報: 英文 253 Pages
概要

世界の細胞培養の市場は2015年から2020年にかけて10.5%のCAGR (複合年間成長率) で推移し、2015年の113億1090万米ドルから、2020年には186億3070万米ドルの規模に成長すると予測されています。慢性疾患の発症率の拡大や、承認済み細胞培養ベースワクチンの増加、mAbの需要の拡大、細胞関連研究への資金供給、単回利用技術利用の増加、細胞培養製品の技術的進歩などが同市場の主な成長推進因子となっています。

当レポートでは、世界の細胞培養の市場について調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、機器・消耗品・用途・エンドユーザー・地域別の主要動向と市場規模の推移と予測、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 容器市場
  • 血清・培地・試薬市場
  • 用途別市場
  • エンドユーザー別市場
  • 地域概要

第5章 市場概要

  • イントロダクション
  • 市場セグメンテーション
    • 製品別
      • 機器別
      • 消耗品別
    • 用途別
    • エンドユーザー別
    • 地域別
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 細胞培養市場:製品別

  • イントロダクション
  • 機器
    • バイオリアクター
      • 従来型バイオリアクター
      • 単回使用バイオリアクター
    • 容器
      • フラスコ
      • ローラー/ルー瓶
      • セルファクトリーシステム/セルスタック
      • ペトリ皿
      • マルチウェルプレート
    • 保存機器
      • 冷蔵庫・冷凍庫
      • クライオストレージシステム
    • 支援機器
      • セルカウンター
      • 濾過システム
      • 遠心分離機
      • 炭酸ガス培養器
      • オートクレーブ
      • 顕微鏡
      • バイオセーフティキャビネット
      • その他
  • 消耗品
    • 血清・培地・試薬
    • バイオリアクター備品

第7章 細胞培養市場:用途別

  • イントロダクション
  • 医薬品・バイオテクノロジー
    • ワクチン生産
    • 診断
    • 組み換えタンパク質
  • 癌研究
  • 幹細胞技術
  • 薬剤スクリーニング・開発
  • 組織工学・再生医療
  • その他

第8章 細胞培養市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 研究機関

第9章 細胞培養市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア
  • その他

第10章 競合環境

  • イントロダクション
  • 市場シェア分析
  • 競合状況・動向
    • 新製品の投入
    • 合意・提携
    • 拡張
    • 買収

第11章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • GE HEALTHCARE
  • LONZA GROUP AG
  • CORNING, INC.
  • BECTON, DICKINSON AND COMPANY
  • EPPENDORF AG
  • HI-MEDIA LABORATORIES
  • SARTORIUS AG
  • PROMOCELL GMBH

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2561

The cell culture market is projected to reach USD 18,630.7 million by 2020 from USD 11,310.9 million in 2015, at a CAGR of 10.5%. This market is categorized on the basis of products, applications, end users, and regions.

Major factors contributing to the growth of the global cell culture market include the increasing incidence of chronic diseases, growth in number of regulatory approvals for cell culture-based vaccines, growing demand for mAbs, funding for cell-based research, rising adoption of single-use technologies, and technological advancements in cell culture products. However, factors such as high cost of research in cell biology and lack of infrastructure for cell-based research are likely to hinder the growth of this market during the forecast period.

The cell culture market in Asia is expected to witness the highest growth rate from 2015-2020. Emerging economies such as China and India preferred destinations for major pharmaceutical giants as the cost of production is significantly lower compared to developed nations. Moreover, regulatory norms in these countries are less stringent and the cost of labor is less. This in turn reduces the cost of production of biologics. Owing to these benefits, various pharmaceutical giants are actively investing in these markets to develop biopharmaceutical drugs. For instance, in June 2013, Boehringer Ingelheim (Germany) invested €35 million (USD 46.4 million) to establish a cGMP biopharmaceutical manufacturing facility in China.

Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. The company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The above mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the cell culture market. The report analyzes the cell culture market by product, applications, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the cell culture market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the cell culture market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for cell culture market across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the cell culture market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATION
  • 1.6. STAKE HOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL CULTURE MARKET OVERVIEW
  • 4.2. CELL CULTURE VESSELS MARKET
  • 4.3. CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET
  • 4.4. CELL CULTURE MARKET, BY APPLICATION
  • 4.5. CELL CULTURE MARKET, BY END USER
  • 4.6. CELL CULTURE MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT
      • 5.2.1.1. BY EQUIPMENT
      • 5.2.1.2. BY CONSUMABLE
    • 5.2.2. BY APPLICATION
    • 5.2.3. BY END USER
    • 5.2.4. BY REGION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Growing awareness on the benefits of, and rising regulatory approvals for, cell culture-based vaccines
      • 5.3.1.2. Increase in demand for monoclonal antibodies (mAbs)
      • 5.3.1.3. Funding for cell-based research
      • 5.3.1.4. Growing preference for single-use technologies
      • 5.3.1.5. Technological advancements
    • 5.3.2. MARKET RESTRAINTS
      • 5.3.2.1. High cost of cell biology research
      • 5.3.2.2. Lack of infrastructure for cell-based research in emerging economies
    • 5.3.3. MARKET OPPORTUNITIES
      • 5.3.3.1. 3D cell culture
      • 5.3.3.2. Increased risk of pandemics and communicable diseases
      • 5.3.3.3. Emerging Economies
    • 5.3.4. MARKET CHALLENGES
      • 5.3.4.1. Survival of new entrants

6. CELL CULTURE MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. EQUIPMENT
    • 6.2.1. BIOREACTORS
      • 6.2.1.1. Conventional bioreactors
      • 6.2.1.2. Single-use bioreactors
    • 6.2.2. CELL CULTURE VESSELS
      • 6.2.2.1. Flasks
      • 6.2.2.2. Roller/Roux Bottles
      • 6.2.2.3. Cell Factory Systems/Cell Stacks
      • 6.2.2.4. Petri Dishes
      • 6.2.2.5. Multiwell plates
    • 6.2.3. CELL CULTURE STORAGE EQUIPMENT
      • 6.2.3.1. Refrigerators and Freezers
      • 6.2.3.2. Cryostorage Systems
    • 6.2.4. CELL CULTURE SUPPORTING EQUIPMENT
      • 6.2.4.1. Cell Counters
      • 6.2.4.2. Filtration Systems
      • 6.2.4.3. Centrifuges
      • 6.2.4.4. CO2 Incubators
      • 6.2.4.5. Autoclaves
      • 6.2.4.6. Microscopes
      • 6.2.4.7. Biosafety Cabinets
      • 6.2.4.8. Other Cell Culture Supporting Equipment
  • 6.3. CONSUMABLES
    • 6.3.1. SERA, MEDIA, AND REAGENTS
      • 6.3.1.1. Sera
        • 6.3.1.1.1. Fetal Bovine Sera (FBS)
        • 6.3.1.1.2. Adult Bovine Sera (ABS)
        • 6.3.1.1.3. Other Animal Sera
      • 6.3.1.2. Media
        • 6.3.1.2.1. Classical Media & Salts
        • 6.3.1.2.2. Serum-free media
        • 6.3.1.2.3. Specialty media
        • 6.3.1.2.4. Stem cell culture media
      • 6.3.1.3. Reagents
        • 6.3.1.3.1. Supplements and growth factors
        • 6.3.1.3.2. Buffers and chemicals
        • 6.3.1.3.3. Cell dissociation reagents
        • 6.3.1.3.4. Balanced salt solutions
        • 6.3.1.3.5. Cryoprotective reagents
        • 6.3.1.3.6. Contamination detection kits
        • 6.3.1.3.7. Antibiotics/Antimycotics
        • 6.3.1.3.8. Attachment & Matrix factors
        • 6.3.1.3.9. Other reagents
    • 6.3.2. BIOREACTOR ACCESSORIES

7. CELL CULTURE MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS
    • 7.2.1. VACCINE PRODUCTION
    • 7.2.2. DIAGNOSTICS
    • 7.2.3. RECOMBINANT THERAPEUTIC PROTEINS
  • 7.3. CANCER RESEARCH
  • 7.4. STEM CELL TECHNOLOGIES
  • 7.5. DRUG SCREENING & DEVELOPMENT
  • 7.6. TISSUE ENGINEERING & REGENERATIVE MEDICINE
  • 7.7. OTHER APPLICATIONS

8. CELL CULTURE MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.3. RESEARCH INSTITUTES

9. CELL CULTURE MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES
    • 10.3.2. AGREEMENTS AND COLLABORATIONS
    • 10.3.3. EXPANSIONS
    • 10.3.4. ACQUISITIONS

11. COMPANY PROFILES*

  • 11.1. INTRODUCTION
  • 11.2. THERMO FISHER SCIENTIFIC, INC.
  • 11.3. MERCK KGAA
  • 11.4. GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 11.5. LONZA GROUP AG
  • 11.6. CORNING, INC.
  • 11.7. BECTON, DICKINSON AND COMPANY
  • 11.8. EPPENDORF AG
  • 11.9. HI-MEDIA LABORATORIES
  • 11.10. SARTORIUS AG
  • 11.11. PROMOCELL GMBH

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATION
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: U.S. GOVERNMENT FUNDING FOR STEM CELL RESEARCH
  • TABLE 2: GROWING AWARENESS ON THE BENEFITS OF CELL-CULTURE BASED VACCINES: A MAJOR DRIVER FOR MARKET GROWTH
  • TABLE 3: HIGH COST OF CELL BIOLOGY RESEARCH A MAJOR RESTRAIN FOR MARKET GROWTH
  • TABLE 4: EMERGING 3D CELL CULTURE TECHNOLOGIES, DEVELOPING ECONOMIES EXPECTED TO OFFER HIGH GROWTH OPPORTUNITIES
  • TABLE 5: SURVIVAL OF NEW ENTRANTS IN CELL CULTURE MARKET, A MAJOR CHALLENGE TO MARKET GROWTH
  • TABLE 6: GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 7: CELL CULTURE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: CELL CULTURE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: NORTH AMERICA: CELL CULTURE EQUIPMENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: NORTH AMERICA: BIOREACTORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: CONVENTIONAL BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 18: CELL CULTURE VESSELS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: CELL CULTURE VESSELS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: CELL CULTURE FLASKS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: NORTH AMERICA: CELL CULTURE FLASKS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: ROLLER BOTTLES/ROUX BOTTLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: ROLLER BOTTLES/ROUX BOTTLES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: CELL FACTORY/CELL STACKS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CELL FACTORY/CELL STACKS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: PETRI DISHES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NORTH AMERICA: PETRI DISHES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: MULTIWELL PLATES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: MULTIWELL PLATES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: REFRIGERATORS & FREEZERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 35: CRYOSTORAGE SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CRYOSTORAGE SYSTEMS SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY COUNTRY 2013-2020 (USD MILLION)
  • TABLE 40: CELL COUNTERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CELL COUNTERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 42: FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 44: CENTRIFUGES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CENTRIFUGES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: CO2 INCUBATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: CO2 INCUBATORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 48: AUTOCLAVES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 49: NORTH AMERICA: AUTOCLAVES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 50: MICROSCOPES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 51: NORTH AMERICA: MICROSCOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 52: BIOSAFETY CABINETS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 53: NORTH AMERICA: BIOSAFETY CABINETS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 54: OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 55: NORTH AMERICA: OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 56: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2015 (USD MILLION)
  • TABLE 57: CELL CULTURE CONSUMABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 58: NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 59: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 61: NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 62: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: SERA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 64: NORTH AMERICA: SERA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 65: FETAL BOVINE SERA (FBS) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 66: NORTH AMERICA: FETAL BOVINE SERA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 67: ADULT BOVINE SERA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 68: NORTH AMERICA: ADULT BOVINE SERA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 69: OTHER ANIMAL SERA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 70: NORTH AMERICA: OTHER ANIMAL SERA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 71: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: MEDIA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 73: NORTH AMERICA: MEDIA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 74: CLASSICAL MEDIA & SALTS, MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 75: NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 76: SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 77: NORTH AMERICA: SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 78: SPECIALTY MEDIA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 79: NORTH AMERICA: SPECIALTY MEDIA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 80: STEM CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 81: NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 82: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 83: REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 84: NORTH AMERICA: REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 85: SUPPLEMENTS AND GROWTH FACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 86: NORTH AMERICA: SUPPLEMENTS AND GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 87: BUFFERS & CHEMICALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 88: NORTH AMERICA: BUFFERS & CHEMICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 89: CELL DISSOCIATION REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 90: NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 91: BALANCED SALT SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 92: NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 93: CRYOPROTECTIVE REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 94: NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 95: CONTAMINATION DETECTION KITS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 96: NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 97: ANTIBIOTICS/ANTIMYCOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 98: ANTIBIOTICS/ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 99: ATTACHMENT & MATRIX FACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 100: NORTH AMERICA: ATTACHMENT & MATRIX FACTORS, MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 101: OTHER REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 102: NORTH AMERICA: OTHER REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 103: BIOREACTOR ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 104: NORTH AMERICA: BIOREACTOR ACCESSORIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 105: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 106: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 107: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 108: NORTH AMERICA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 109: VACCINE PRODUCTION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 110: NORTH AMERICA: VACCINE PRODUCTION MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 111: DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 112: NORTH AMERICA: DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 113: RECOMBINANT THERAPEUTIC PROTEINS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 114: NORTH AMERICA: RECOMBINANT THERAPEUTIC PROTEINS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 115: CANCER RESEARCH MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 116: NORTH AMERICA: CANCER RESEARCH MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 117: STEM CELL TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 118: NORTH AMERICA: STEM CELL TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 119: DRUG SCREENING & DEVELOPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 120: NORTH AMERICA: DRUG SCREENING & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 121: TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 122: NORTH AMERICA: TISSUE REGENERATION & REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 123: OTHER APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 124: NORTH AMERICA: OTHER APPLICATIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 125: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 126: CELL CULTURE MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 127: NORTH AMERICA: CELL CULTURE MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 128: CELL CULTURE MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 129: NORTH AMERICA: CELL CULTURE MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 130: GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 131: NORTH AMERICA: CELL CULTURE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 132: NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 133: NORTH AMERICA: CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2013-2020 (USD MILLION)
  • TABLE 134: NORTH AMERICA: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 135: NORTH AMERICA: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 136: NORTH AMERICA: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 137: NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 138: NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 139: NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 140: NORTH AMERICA: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 141: NORTH AMERICA: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 142: NORTH AMERICA: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 143: NORTH AMERICA: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 144: NORTH AMERICA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 145: NORTH AMERICA: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 146: U.S.: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 147: U.S.: CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2013-2020 (USD MILLION)
  • TABLE 148: U.S.: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 149: U.S.: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 150: U.S.: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 151: U.S.: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 152: U.S.: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 153: U.S.: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 154: U.S.: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 155: U.S.: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 156: U.S.: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 157: U.S.: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 158: U.S.: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 159: U.S.: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 160: CANADA: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 161: CANADA: CELL CULTURE MARKET SIZE, BY EQUIPMENTS, 2013-2020 (USD MILLION)
  • TABLE 162: CANADA: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 163: CANADA: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 164: CANADA: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 165: CANADA: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 166: CANADA: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 167: CANADA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 168: CANADA: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 169: CANADA: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 170: CANADA: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 171: CANADA: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 172: CANADA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 173: CANADA: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 174: EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 175: EUROPE: CELL CULTURE MARKET SIZE, BY EQUIPMENTS, 2013-2020 (USD MILLION)
  • TABLE 176: EUROPE: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 177: EUROPE: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 178: EUROPE: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 179: EUROPE: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 180: EUROPE: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 181: EUROPE: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 182: EUROPE: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 183: EUROPE: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 184: EUROPE: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 185: EUROPE: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 186: EUROPE: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 187: EUROPE: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 188: ASIA: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 189: ASIA: CELL CULTURE MARKET SIZE, BY EQUIPMENTS, 2013-2020 (USD MILLION)
  • TABLE 190: ASIA: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 191: ASIA: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 192: ASIA: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 193: ASIA: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 194: ASIA: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 195: ASIA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 196: ASIA: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 197: ASIA: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 198: ASIA: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 199: ASIA: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 200: ASIA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 201: ASIA: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 202: ROW: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 203: ROW: CELL CULTURE MARKET SIZE, BY EQUIPMENTS, 2013-2020 (USD MILLION)
  • TABLE 204: ROW: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 205: ROW: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 206: ROW: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 207: ROW: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 208: ROW: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 209: ROW: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 210: ROW: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 211: ROW: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 212: ROW: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 213: ROW: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 214: ROW: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 215: ROW: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 216: NEW PRODUCT LAUNCHES
  • TABLE 217: AGREEMENTS AND COLLABORATIONS
  • TABLE 218: EXPANSIONS
  • TABLE 219: ACQUISITIONS
  • TABLE 220: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 221: EXCHANGE RATES (USED FOR THE CONVERSION OF CHF TO USD)
  • TABLE 222: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 223: EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
  • TABLE 224: THERMO FISHER SCIENTIFIC, INC.
  • TABLE 225: MERCK KGAA
  • TABLE 226: GE HEALTHCARE
  • TABLE 227: LONZA GROUP AG
  • TABLE 228: CORNING, INC.
  • TABLE 229: BECTON, DICKINSON AND COMPANY
  • TABLE 230: EPPENDORF AG
  • TABLE 231: SARTORIUS AG
  • TABLE 232: PROMOCELL GMBH

LIST OF FIGURES

  • FIGURE 1: CELL CULTURE MARKET, BY PRODUCT
  • FIGURE 2: CELL CULTURE MARKET, BY INSTRUMENT
  • FIGURE 3: CELL CULTURE MARKET, BY CONSUMABLE
  • FIGURE 4: RESEARCH DESIGN
  • FIGURE 5: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 7: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 10: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 11: CELL CULTURE MARKET SNAPSHOT, BY PRODUCT, 2015 VS. 2020
  • FIGURE 12: BIOPHARMACEUTICAL/THERAPEUTICS IS THE FASTEST-GROWING APPLICATION SEGMENT
  • FIGURE 13: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO HOLD THE LARGEST SHARE DURING THE FORECAST PERIOD (2015-2020)
  • FIGURE 14: CELL CULTURE MARKET, BY REGION: ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 15: NEW PRODUCT LAUNCHES & AGREEMENTS AND COLLABORATIONS ARE THE KEY STRATEGIES ADOPTED BY THE MARKET PLAYERS DURING THE FORECAST PERIOD
  • FIGURE 16: GROWING AWARENESS ON THE BENEFITS OF CELL CULTURE-BASED VACCINES-A MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 17: MARKET SHARE (2015) FOR TOP FOUR CELL CULTURE VESSELS
  • FIGURE 18: FETAL BOVINE SERA TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020
  • FIGURE 19: BIOPHARMACEUTICAL/THERAPEUTICS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 20: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 21: ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 22: CELL CULTURE MARKET, BY PRODUCT
  • FIGURE 23: CELL CULTURE MARKET, BY EQUIPMENT
  • FIGURE 24: CELL CULTURE MARKET, BY CONSUMABLE
  • FIGURE 25: CELL CULTURE MARKET, BY APPLICATION
  • FIGURE 26: CELL CULTURE MARKET, BY END USER
  • FIGURE 27: CELL CULTURE MARKET SEGMENTATION, BY REGION
  • FIGURE 28: CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29: CONSUMABLES TO DOMINATE CELL CULTURE PRODUCTS MARKET
  • FIGURE 30: BIOREACTORS TO WITNESS HIGHEST GROWTH IN CELL CULTURE EQUIPMENT MARKET
  • FIGURE 31: CONVENTIONAL BIOREACTORS TO DOMINATE THE MARKET DURING FORECAST PERIOD (2015-2020)
  • FIGURE 32: ROLLER BOTTLES/ROUX BOTTLES TO DOMINATE CELL CULTURE VESSEL MARKET
  • FIGURE 33: REFRIGERATORS & FREEZERS TO COMMAND LARGEST SHARE OF CELL CULTURE MARKET BY EQUIPMENT IN 2015
  • FIGURE 34: FILTRATION SYSTEMS TO DOMINATE THE CELL CULTURE SUPPORTING EQUIPMENT MARKET
  • FIGURE 35: ASIA TO WITNESS HIGHEST GROWTH RATE IN CELL CULTURE CONSUMABLE MARKET
  • FIGURE 36: FETAL BOVINE SERA (FBS) TO DOMINATE THE CELL CULTURE SERA MARKET DURING 2015-2020
  • FIGURE 37: SUPPLEMENTS AND GROWTH FACTORS TO DOMINATE THE REAGENT MARKET
  • FIGURE 38: BIOPHARMACEUTICALS/THERAPEUTICS APPLICATION SEGMENT TO DOMINATE CELL CULTURE MARKET DURING THE FORECAST PERIOD (2015-2020)
  • FIGURE 39: VACCINE PRODUCTION TO COMMAND LARGEST SHARE OF THE BIOPHARMACEUTICAL/THERAPEUTICS MARKET
  • FIGURE 40: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CELL CULTURE MARKET FROM 2015 TO 2020
  • FIGURE 41: ASIA TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2015-2020)
  • FIGURE 42: NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT (2015)
  • FIGURE 43: EUROPE: CELL CULTURE MARKET SNAPSHOT (2015)
  • FIGURE 44: ASIA: CELL CULTURE MARKET SNAPSHOT (2015)
  • FIGURE 45: REST OF THE WORLD (ROW): CELL CULTURE MARKET SNAPSHOT (2015)
  • FIGURE 46: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2012 AND 2015
  • FIGURE 47: MARKET EVOLUTION FRAMEWORK
  • FIGURE 48: MARKET SHARE OF KEY PLAYERS IN THE CELL CULTURE SERA, MEDIA, & REAGENTS MARKET (2014)
  • FIGURE 49: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY THE MARKET PLAYERS
  • FIGURE 50: GEOGRAPHIC REVENUE MIX OF KEY PLAYERS
  • FIGURE 51: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 52: COMPANY SNAPSHOT: MERCK MILLIPORE
  • FIGURE 53: COMPANY SNAPSHOT: GE HEALTHCARE
  • FIGURE 54: COMPANY SNAPSHOT: LONZA GROUP AG
  • FIGURE 55: COMPANY SNAPSHOT: CORNING, INC.
  • FIGURE 56: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 57: COMPANY SNAPSHOT: EPPENDORF AG
  • FIGURE 58: COMPANY SNAPSHOT: SARTORIUS AG
Back to Top